111 related articles for article (PubMed ID: 16303248)
1. Delivery of hypericin for photodynamic applications.
Saw CL; Olivo M; Soo KC; Heng PW
Cancer Lett; 2006 Sep; 241(1):23-30. PubMed ID: 16303248
[TBL] [Abstract][Full Text] [Related]
2. Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer.
Zeisser-Labouèbe M; Mattiuzzo M; Lange N; Gurny R; Delie F
J Drug Target; 2009 Sep; 17(8):619-26. PubMed ID: 19589125
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic-free nanotherapeutics: hypericin nanoparticles thereof for improved in vitro and in vivo antimicrobial photodynamic therapy and wound healing.
Nafee N; Youssef A; El-Gowelli H; Asem H; Kandil S
Int J Pharm; 2013 Sep; 454(1):249-58. PubMed ID: 23834835
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin.
Kubin A; Meissner P; Wierrani F; Burner U; Bodenteich A; Pytel A; Schmeller N
Photochem Photobiol; 2008; 84(6):1560-3. PubMed ID: 18627521
[TBL] [Abstract][Full Text] [Related]
5. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines.
Ritz R; Wein HT; Dietz K; Schenk M; Roser F; Tatagiba M; Strauss WS
Int J Oncol; 2007 Mar; 30(3):659-67. PubMed ID: 17273767
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
[TBL] [Abstract][Full Text] [Related]
8. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
Kamuhabwa A; Agostinis P; Ahmed B; Landuyt W; van Cleynenbreugel B; van Poppel H; de Witte P
Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
[TBL] [Abstract][Full Text] [Related]
9. Hypericin for visualization of high grade gliomas: first clinical experience.
Ritz R; Daniels R; Noell S; Feigl GC; Schmidt V; Bornemann A; Ramina K; Mayer D; Dietz K; Strauss WS; Tatagiba M
Eur J Surg Oncol; 2012 Apr; 38(4):352-60. PubMed ID: 22284346
[TBL] [Abstract][Full Text] [Related]
10. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
Boiy A; Roelandts R; van den Oord J; de Witte PA
Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the antitumor selectivity of PVP-Hypericin re A549 cancer cells and HLF normal cells through pulsed blue light.
Penjweini R; Loew HG; Breit P; Kratky KW
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):591-9. PubMed ID: 24284116
[TBL] [Abstract][Full Text] [Related]
12. Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy.
Bobrov N; Cavarga I; Longauer F; Rybárová S; Fedorocko P; Brezáni P; Miskovský P; Mirossay L; Stubna J
Phytomedicine; 2007 Feb; 14(2-3):172-8. PubMed ID: 17095201
[TBL] [Abstract][Full Text] [Related]
13. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
Seitz G; Krause R; Fuchs J; Heitmann H; Armeanu S; Ruck P; Warmann SW
Oncol Rep; 2008 Nov; 20(5):1277-82. PubMed ID: 18949433
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic efficiency of hypericin compared with chlorin and hematoporphyrin derivatives in HEp-2 and Vero epithelial cell lines.
Bernal C; Ribeiro AO; Andrade GP; Perussi JR
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):176-85. PubMed ID: 25910552
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines.
Stupáková V; Varinská L; Mirossay A; Sarisský M; Mojzis J; Dankovcík R; Urdzík P; Ostró A; Mirossay L
Phytother Res; 2009 Jun; 23(6):827-32. PubMed ID: 19173218
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of hypericin for photodynamic therapy of equine sarcoids.
Martens A; de Moor A; Waelkens E; Merlevede W; De Witte P
Vet J; 2000 Jan; 159(1):77-84. PubMed ID: 10640414
[TBL] [Abstract][Full Text] [Related]
17. The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer.
Jain S; Kockelbergh RC
BJU Int; 2005 Jul; 96(1):17-21. PubMed ID: 15963113
[No Abstract] [Full Text] [Related]
18. Delivering a hydrophobic anticancer drug for photodynamic therapy by amorphous formulation.
Zhou L; Wang W; Feng Y; Wei S; Zhou J; Yu B; Shen J
Bioorg Med Chem Lett; 2010 Nov; 20(21):6172-4. PubMed ID: 20850314
[TBL] [Abstract][Full Text] [Related]
19. In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder.
Huygens A; Kamuhabwa AR; van Cleynenbreugel B; van Poppel H; Roskams T; de Witte PA
BJU Int; 2005 Feb; 95(3):436-41. PubMed ID: 15679810
[TBL] [Abstract][Full Text] [Related]
20. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
Du HY; Li Y; Olivo M; Yip GW; Bay BH
Oncol Rep; 2006 Dec; 16(6):1397-402. PubMed ID: 17089067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
